Cancer Innovation

ISSN 2770-9191 e-ISSN 2770-9183 CN 10-1951/R73
Editor-in-Chief: Fei Ma
Open Access
Journal Home > Previous Issue
Previous Issue
Volume 1
Issue 1, June 2022
pp.1-118 8 articles
Open Access Editorial
The inauguration of Cancer Innovation: Leading New Frontiers in Oncology, Building Human Health Community
https://doi.org/10.1002/cai2.19
Published: 15 June 2022
2022, 1 (1): 1-2
Downloads: 41 | Views: 289 | PDF (218.1 KB)
Open Access Clinical Guideline
Expert consensus on the clinical application of antibody‐drug conjugates in the treatment of malignant tumors (2021 edition)
https://doi.org/10.1002/cai2.8
Published: 19 June 2022
2022, 1 (1): 3-24
Downloads: 34 | Views: 779 | PDF (1.5 MB)
Open Access Clinical Guideline
Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer
https://doi.org/10.1002/cai2.10
Published: 21 June 2022
2022, 1 (1): 25-54
Downloads: 59 | Views: 970 | PDF (2.3 MB)
Open Access Original Article
ATF4/TXNIP/REDD1/mTOR signaling mediates the antitumor activities of liver X receptor in pancreatic cancers
https://doi.org/10.1002/cai2.12
Published: 30 June 2022
2022, 1 (1): 55-69
Downloads: 55 | Views: 1034 | PDF (7.6 MB)
Open Access Original Article
Genetic variants in XPD gene and glioma susceptibility in Chinese children: A multicenter case–control study
https://doi.org/10.1002/cai2.6
Published: 30 June 2022
2022, 1 (1): 70-79
Downloads: 59 | Views: 1063 | PDF (1.8 MB)
Open Access Review
Application of informatics in cancer research and clinical practice: Opportunities and challenges
https://doi.org/10.1002/cai2.9
Published: 15 June 2022
2022, 1 (1): 80-91
Downloads: 27 | Views: 562 | PDF (1.3 MB)
Open Access Review
Crosstalk between ferroptosis and stress—Implications in cancer therapeutic responses
https://doi.org/10.1002/cai2.7
Published: 11 June 2022
2022, 1 (1): 92-113
Downloads: 79 | Views: 945 | PDF (3 MB)
Open Access Case Report
Identification of novel somatic fusions of ERG‐VEGFA, TMPRSS2‐ERG, and VEGFA‐TMPRSS2 in prostate cancer treated with anlotinib and androgen deprivation therapy: A case report
https://doi.org/10.1002/cai2.11
Published: 09 June 2022
2022, 1 (1): 114-118
Downloads: 41 | Views: 880 | PDF (1.6 MB)